Category: Studies

Peer-reviewed studies covering cannabis and cannabis compounds.

CBG Found to Trigger Multiple Cancer Cell Death Pathways in Pancreatic Tumor Cells

New research published in Free Radical Biology and Medicine found that cannabigerol (CBG) may have strong anti-cancer effects against pancreatic cancer cells, with researchers saying the compound slowed cell growth and triggered multiple forms of programmed cell death.

Continue reading

Aerobic Exercise Linked to Reduced Migraines and Changes in Endocannabinoid Levels, Study Finds

A randomized clinical trial published in Cannabis and Cannabinoid Research found that regular aerobic exercise may significantly reduce migraine frequency while also altering levels of anandamide, a key endocannabinoid tied to pain and mood regulation.

Continue reading

Study Finds Cannabinoids May Help Protect Cognitive Function in Parkinson’s Disease

A study published today in Neuroscience by researchers from the Russian Academy of Sciences finds that cannabinoid-based treatments may have potential to help preserve cognitive function in people with Parkinson’s disease.

Continue reading

Study: Fennel Oil and Yeast Lysate Boost Marijuana Disease Resistance and Cannabinoid Levels

A new study published in Industrial Crops and Products found that a combination of fennel essential oil, yeast lysate and beneficial microbes may help marijuana plants fight off disease and pests while also increasing levels of key cannabinoids.

Continue reading

Study: Marijuana Extract Shows Strong Antibacterial Potential Against Fish Pathogens

A study published this month by the peer-reviewed journal Frontiers in Veterinary Science found that leaf extracts from marijuana may help fight bacterial infections in fish by limiting bacterial growth, disrupting biofilms and interfering with quorum sensing, a communication process bacteria use to coordinate harmful activity.

Continue reading

Study: CBD May Reduce a Key Ketamine Side Effect While Preserving Antidepressant Potential

A study published online today by the journal Biological Psychiatry reports that cannabidiol (CBD) may help reduce a major side effect of ketamine by targeting a specific receptor in the brain tied to movement and dopamine activity.

Continue reading

Study: CBD and Probiotics May Work Together to Support the Gut-Brain Axis

A study published in CNS & Neurological Disorders – Drug Targets finds that cannabidiol (CBD) and probiotics may have complementary effects on the gut-brain axis, a communication system linking the digestive tract and central nervous system.

Continue reading

CBD Shows Multi-Target Potential Against Breast Cancer Pathways, Study Finds

The cannabis compound cannabidiol (CBD) interacts strongly with several proteins tied to breast cancer growth and spread, highlighting its potential as a multi-target treatment candidate, according to a new study published in Current Drug Discovery Technologies.

Continue reading

Study: Delta-8 THC May Dramatically Slow Nicotine Metabolism, Raising Smoking Cessation Potential

A new study published in Drug Metabolism and Disposition found that delta-8 THC can sharply inhibit the body’s ability to break down nicotine, suggesting it may have potential as a smoking-cessation aid.

Continue reading

Study: CBD-Dominant Marijuana Extracts Outperform THC in Older Adults With Chronic Pain, Although Both Help

A new study published in the Journal of Pain Research found that CBD-dominant full-spectrum marijuana extracts were associated with stronger pain relief and fewer side effects than pure THC in older adults with chronic or treatment-resistant pain.

Continue reading